Skip to content

Neogen NEOG EV / EBITDA

EV / EBITDA at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
21.3×-3.5×
Idexx Laboratories logo
Idexx LaboratoriesIDXX
28.9×+1.9×
Zoetis logo
ZoetisZTS
14.4×-5.9×
Revvity logo
RevvityRVTY
16.7×-2.2×
Agilent Technologies logo
Agilent TechnologiesA
18.8×-0.5×
Merck & Co. logo
Merck & Co.MRK
23.1×+11.7×

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2B+86.4%
Enterprise value$2.63B+41.6%
P/S2.3×+1.1×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

Based on the most recent quarter.

The official record: Neogen’s 10-Q, filed October 10, 2024, on SEC EDGAR. View the filing →

Ask your AI about Neogen's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's EV / EBITDA?
Neogen (NEOG) reported EV / EBITDA of 28.3× in Q2 2024.
How has Neogen's EV / EBITDA changed year-over-year?
Neogen's EV / EBITDA decreased by 20.1% year-over-year, from 35.4× to 28.3×.
What is the long-term trend for Neogen's EV / EBITDA?
Over 3 years (2021 to 2024), Neogen's EV / EBITDA has grown at a -26.5% compound annual growth rate (CAGR), from 51.5× to 20.4×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.